Cases 71 - 80 of 2,769
Hi-Tech Pharmaceuticals, Inc. v. Nutrition Resource Services, Inc.
as 1:2023cv05536
Plaintiff:
Hi-Tech Pharmaceuticals, Inc.
Defendant:
Nutrition Resource Services, Inc. doing business as JBN - Just Be Natural
Cause Of Action: 28 U.S.C. § 2201 Declaratory Judgment
Bayer Pharma AG et al v. Aurobindo Pharma Limited et al
as 1:2023cv01372
Plaintiff:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Regeneron Pharmaceuticals, Inc. v. Formycon AG
as 1:2023cv00097
Plaintiff:
Regeneron Pharmaceuticals, Inc.
Defendant:
Formycon AG
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Regeneron Pharmaceuticals, Inc. v. Samsung Bioepis, CO., LTD.,
as 1:2023cv00094
Plaintiff:
Regeneron Pharmaceuticals, Inc.
Defendant:
Samsung Bioepis, CO., LTD.,
Cause Of Action: 35 U.S.C. § 145 Patent Infringement
Catalyst Pharmaceuticals, Inc. et al v. Inventia Healthcare Limited
as 1:2023cv01331
Plaintiff:
Catalyst Pharmaceuticals, Inc. and SERB SA
Defendant:
Inventia Healthcare Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
CATALYST PHARMACEUTICALS, INC. et al v. INVENTIA HEALTHCARE LIMITED
as 2:2023cv22461
Plaintiff:
CATALYST PHARMACEUTICALS, INC. and SERB SA
Defendant:
INVENTIA HEALTHCARE LIMITED
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
PURDUE PHARMA L.P. et al
as 2:2023cv22221
Plaintiff:
PURDUE PHARMA L.P., PURDUE PHARMACEUTICALS L.P. and RHODES TECHNOLOGIES
Defendant:
ELITE LABORATORIES, INC. and ELITE PHARMACEUTICALS, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
PURDUE PHARMA L.P. et al v ELITE LABORATORIES INC, et al.
as 1:2023cv22221
Plaintiff:
PURDUE PHARMA L.P., PURDUE PHARMACEUTICALS L.P. and RHODES TECHNOLOGIES
Defendant:
ELITE LABORATORIES, INC. and ELITE PHARMACEUTICALS, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Harmony Biosciences, LLC et al v. Lupin Limited et al
as 1:2023cv01286
Plaintiff:
Harmony Biosciences, LLC, Bioprojet Societe Civile de Recherche and Bioprojet Pharma SAS
Defendant:
Lupin Limited, Lupin Pharmaceuticals, Inc., Novugen Pharma Sdn. Bhd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc.
as 1:2023cv00089
Plaintiff:
Regeneron Pharmaceuticals, Inc.
Defendant:
Celltrion, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
